A detailed history of Voya Investment Management LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 33,941 shares of CPRX stock, worth $525,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares
33,941
Previous 39,935 15.01%
Holding current value
$525,746
Previous $671,000 19.37%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$13.18 - $17.11 $79,000 - $102,557
-5,994 Reduced 15.01%
33,941 $541,000
Q4 2023

Feb 14, 2024

BUY
$11.78 - $17.29 $6,349 - $9,319
539 Added 1.37%
39,935 $671,000
Q3 2023

Nov 14, 2023

SELL
$11.69 - $15.02 $2.76 Million - $3.54 Million
-235,934 Reduced 85.69%
39,396 $460,000
Q2 2023

Aug 14, 2023

BUY
$11.5 - $18.08 $2.66 Million - $4.17 Million
230,901 Added 519.71%
275,330 $3.7 Million
Q1 2023

May 15, 2023

SELL
$14.34 - $21.05 $171,219 - $251,337
-11,940 Reduced 21.18%
44,429 $736,000
Q4 2022

Feb 14, 2023

SELL
$12.25 - $19.5 $30,845 - $49,101
-2,518 Reduced 4.28%
56,369 $1.05 Million
Q3 2022

Mar 03, 2023

BUY
$7.06 - $15.52 $17,777 - $39,079
2,518 Added 4.47%
58,887 $755,000
Q3 2022

Nov 14, 2022

BUY
$7.06 - $15.52 $151,338 - $332,686
21,436 Added 57.24%
58,887 $756,000
Q2 2022

Aug 15, 2022

SELL
$6.23 - $8.57 $8,123 - $11,175
-1,304 Reduced 3.36%
37,451 $263,000
Q4 2021

Feb 14, 2022

SELL
$5.21 - $7.45 $4,850 - $6,935
-931 Reduced 2.35%
38,755 $262,000
Q2 2021

Aug 16, 2021

SELL
$4.29 - $6.05 $25,010 - $35,271
-5,830 Reduced 12.81%
39,686 $228,000
Q1 2021

May 17, 2021

BUY
$3.45 - $4.69 $10,291 - $13,990
2,983 Added 7.01%
45,516 $210,000
Q4 2020

Feb 16, 2021

BUY
$2.97 - $3.83 $27,027 - $34,853
9,100 Added 27.22%
42,533 $142,000
Q2 2020

Aug 14, 2020

SELL
$3.48 - $5.05 $51,413 - $74,608
-14,774 Reduced 30.65%
33,433 $154,000
Q4 2019

Feb 14, 2020

BUY
$3.67 - $5.7 $33,518 - $52,058
9,133 Added 23.37%
48,207 $181,000
Q2 2019

Aug 14, 2019

SELL
$2.7 - $6.11 $5,602 - $12,678
-2,075 Reduced 5.04%
39,074 $150,000
Q2 2018

Aug 14, 2018

BUY
$2.26 - $3.84 $18,477 - $31,395
8,176 Added 24.8%
41,149 $128,000
Q3 2017

Nov 14, 2017

BUY
$2.4 - $2.94 $79,135 - $96,940
32,973
32,973 $83,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $1.59B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.